Tibet Cheezheng Tibetan Medicine Co., Ltd. (SHE:002287)

China · Delayed Price · Currency is CNY

19.61

-0.19 (-0.96%)

Jun 18, 2026, 3:04 PM CST

-11.79% (1Y)

Market Cap	11.12B -13.9%
Revenue (ttm)	2.42B +1.8%
Net Income	667.92M +19.2%
EPS	1.21 +14.5%
Shares Out	566.88M
PE Ratio	16.22
Forward PE	n/a
Dividend	0.38 (1.94%)
Ex-Dividend Date	Jun 17, 2026

Volume	1,458,782
Open	20.20
Previous Close	19.80
Day's Range	19.40 - 20.20
52-Week Range	19.40 - 38.16
Beta	0.14
Analysts	Strong Buy
Price Target	28.49 (+45.28%)
Earnings Date	Apr 24, 2026

About SHE:002287

Tibet Cheezheng Tibetan Medicine Co., Ltd. engages in the research, development, production, and sale of Tibetan medicines in China and internationally. The company also provides plasters, topical and oral tibetan medicines, and ointments. Its products are used in areas of orthopedics, neurology, dermatology, granules, gynecology, pediatrics, respiratory, gastroenterology, cardiovascular, musculoskeletal system, nervous system, respiratory, digestive, urinary, and cerebrovascular sectors. The company was founded in 1995 and is based in Nyingchi... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 1995

Employees 3,203

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 002287

Full Company Profile

Financial Performance

In 2025, SHE:002287's revenue was 2.42 billion, an increase of 3.34% compared to the previous year's 2.34 billion. Earnings were 648.43 million, an increase of 11.36%.

Financial Statements